The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.50
Bid: 62.00
Ask: 65.00
Change: 1.00 (1.60%)
Spread: 3.00 (4.839%)
Open: 62.50
High: 63.50
Low: 62.50
Prev. Close: 62.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: NetScientific's PDS temporarily suspends trial recruitment

Fri, 22nd Oct 2021 06:51

NetScientific PLC - London-based life sciences and sustainability, technology investment and commercialisation firm - Portfolio company PDS Biotechnology Corp temporarily suspends recruitment for its National Cancer Institute-led Phase 2 clinical trial evaluating PDS0101, or Versamune-HPV16, in combination with two investigational immune-modulating agents in advanced HPV cancers.

"The issue is not specific to the PDS0101 trial and is unrelated to any safety or efficacy concerns with the triple combination. It is anticipated that this temporary suspension in recruitment for this clinical trial will be determined in a timely manner and is not expected to affect the overall timing of clinical data," NetScientific says.

PDS Biotech Chief Medical Officer Lauren Wood adds: "We know from the interim data that this combination has the potential to significantly improve clinical outcomes for patients with advanced, refractory HPV16-associated cancers who have limited treatment options. While the trial is experiencing a slight administrative delay, we are pleased to report that the PDS0101 trial recruitment has progressed well and it is anticipated that it will resume recruitment shortly."

Current stock price: 98.10 pence, closing down 20% on Thursday

Year-to-date change: doubled from 46.50p

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Jun 2020 19:03

IN BRIEF: NetScientific Investee PDS Inks Covid Pact With Farmacore

IN BRIEF: NetScientific Investee PDS Inks Covid Pact With Farmacore

Read more
18 Jun 2020 10:21

NetScientific's PDS investment signs deal for Covid-19 vaccine

(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.

Read more
15 Jun 2020 15:44

IN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug

IN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug

Read more
5 Jun 2020 11:21

UK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand

UK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand

Read more
27 Apr 2020 11:15

NetScientific Reports Narrowed Annual Loss On Lower Costs

NetScientific Reports Narrowed Annual Loss On Lower Costs

Read more
17 Apr 2020 11:19

UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis

UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis

Read more
17 Apr 2020 08:12

LONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring

LONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring

Read more
17 Apr 2020 06:56

NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine

NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine

Read more
12 Feb 2020 13:13

NetScientific To Invest Further USD650,000 In PDS Biotechnology

NetScientific To Invest Further USD650,000 In PDS Biotechnology

Read more
11 Feb 2020 15:51

NetScientific Mulls GBP500,000 Investment In PDS Biotech Fundraise

NetScientific Mulls GBP500,000 Investment In PDS Biotech Fundraise

Read more
15 Jan 2020 12:04

NetScientific CEO And CFO Ian Postlethwaite To Step Down In July

NetScientific CEO And CFO Ian Postlethwaite To Step Down In July

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
13 Dec 2019 15:26

NetScientific Hires Former PwC Clarkson As Director, Wilson Steps Down

NetScientific Hires Former PwC Clarkson As Director, Wilson Steps Down

Read more
21 Nov 2019 12:37

NetScientific's Glycotest Gets USD3 Million More From Fosun Pharma

NetScientific's Glycotest Gets USD3 Million More From Fosun Pharma

Read more
14 Oct 2019 11:20

NetScientific Appoints EMV Capital Managing Director As Non-Executive

NetScientific Appoints EMV Capital Managing Director As Non-Executive

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.